Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Varenicline in Ambivalent Smokers

NCT00595868 is registered in ClinicalTrials.gov with University of Vermont Medical Center as lead sponsor.

NCT NCT00595868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00595868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Varenicline in Ambivalent Smokers
Lead sponsor
University of Vermont Medical Center
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
January 31, 2010
Enrollment
220 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, tobacco use cessation, tobacco use disorder